Advertisement

Laparoscopic Lymphatic Mapping and Sentinel Node Biopsies for Early-stage Gastric Cancer: The Cause of False Negativity

Abstract

Sentinel node (SN) biopsies might be useful for performing minimally invasive surgery without interrupting surgical curability. This study examined the cause of false negativity during laparoscopic lymphatic mapping and SN biopsies for early-stage gastric cancer. Thirty-seven patients with gastric cancer (preoperative stage T1-2 or N0) who underwent laparoscopic lymph node mapping and SN biopsies between March 2001 and June 2004 were enrolled in this study. The tracer, patent blue and technecium-99m-labeled tin colloid, was injected endoscopically. Blue-stained or radioactive nodes were defined as SNs. Gastrectomy with lymphadenectomy was performed then the results of the SN biopsies were compared with the final diagnosis of the removed lymph nodes in permanent sections. Sentinel nodes were successfully identified in 35 patients (94.6%), and they were positive in 3 of 4 patients with metastatic lymph nodes; sensitivity was 75% and specificity was 100%. Sentinel node status could therefore be used to diagnose lymph node status with 97.1% accuracy. Of 6 SNs with metastasis, 5 showed radioactivity, and only 2 were blue stained. In the false negative case, a radioactive SN with metastasis in the right paracardial region was missed during laparoscopic mapping. An error in laparoscopic intracorporeal detection of the radioactive node with metastasis occurred because we could not eliminate the shine-through effect. We found that during laparoscopic SN mapping there is a high risk of false negativity with SNs located in the right paracardial region. To apply laparoscopic SN mapping to early-stage gastric cancer patients, the shine-through effect must be eliminated because radiotracers are essential for this method.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Figure 1
Figure 2
Figure 3

References

  1. 1.

    U.S. National Institutes of Health Web site. Clinical trials information available from: http://clinicaltrials.gov/ct/gui/info/about

  2. 2.

  3. 3.

  4. 4.

  5. 5.

  6. 6.

  7. 7.

  8. 8.

  9. 9.

  10. 10.

  11. 11.

  12. 12.

  13. 13.

    Schwartz GF, Giuliano AE, Veronesi U; Consensus Conference Committee. Proceedings of the Consensus conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast. April 19 to 22, 2001, Philadelphia, Pennsylvania. Hum Pathol. 2002;33:579–589

  14. 14.

  15. 15.

  16. 16.

Download references

Author information

Correspondence to Masato Kusunoki M.D..

Video Supplement

Video contribution

Video contribution

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tonouchi, H., Mohri, Y., Tanaka, K. et al. Laparoscopic Lymphatic Mapping and Sentinel Node Biopsies for Early-stage Gastric Cancer: The Cause of False Negativity. World J. Surg. 29, 418–421 (2005) doi:10.1007/s00268-004-7732-6

Download citation

Keywords

  • Sentinel Node
  • Sentinel Node Biopsy
  • Gastric Cancer Patient
  • Laparoscopic Gastrectomy
  • False Negative Case